Sorrento Therapeutics, Inc.
SRNEDelisted Apr 12, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000850261
Sorrento Therapeutics, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 20, 2023; 224 institutions reported holding it in 13F filings for Q4 2022, worth $180.7M in total; Oaktree Capital was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Sorrento Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Sorrento Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ji Henry | See Remarks | 20,000Indirect | Mar 20, 2023 | 0 |
| Czerepak Elizabeth | EVP & Chief Financial Officer | – | May 20, 2022 | 0 |
| Reilly Tammy | Director | – | May 20, 2022 | 0 |
| Janda Kim | Director | 3,000 | Dec 27, 2021 | 0 |
| Smith Robin L | Director | 235,000 | Sep 3, 2021 | 0 |
| Shah Jaisim | Director | – | Aug 30, 2021 | 0 |
| Wu Yue Alexander | Director | – | Aug 30, 2021 | 0 |
| Followwill Dorman | Director | – | Aug 30, 2021 | 0 |
| Lemus David | Director | – | Aug 30, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2022 (view filing) | Sep 7 | Same day | Ji HenrySee Remarks | PPurchase | +88.9K | $2.02 | +$179.6K | +1.9%4.77M after | |
| Sep 7, 2022 (view filing) | Sep 7 | Same day | Ji HenrySee Remarks | PPurchase | +88.8K | $0.4081 | +$36.2K | –129 after | Derivative2 lots |
| Sep 6, 2022 (view filing) | Sep 6 | Same day | Ji HenrySee Remarks | PPurchase | +55.6K | $1.96 | +$108.9K | +1.2%4.68M after | |
| Aug 26, 2022 (view filing) | Aug 26 | Same day | Ji HenrySee Remarks | PPurchase | +33.3K | $2.11 | +$70.3K | +1.6%2.12M after | |
| Aug 26, 2022 (view filing) | Aug 26 | Same day | Ji HenrySee Remarks | SSale | −20.0K | $3.49 | −$69.9K | –200 after | Derivative |
| Aug 25, 2022 (view filing) | Aug 25 | Same day | Ji HenrySee Remarks | PPurchase | +22.2K | $2.06 | +$45.8K | +1.1%2.09M after | |
| Aug 25, 2022 (view filing) | Aug 25 | Same day | Ji HenrySee Remarks | PPurchase | +100.0K | $0.3066 | +$30.7K | –1.00K after | Derivative |
| Jun 14, 2022 (view filing) | Jun 14 | Same day | Ji HenrySee Remarks | PPurchase | +10.0K | $1.40 | +$14.0K | +0.5%2.07M after | |
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Janda KimDirector | SSale | −3.00K | $5.88 | −$17.6K | −50.0%3.00K after | |
| Sep 28, 2021 (view filing) | Sep 27 | 1 day | Janda KimDirector | SSale | −42.4K | $8.02 | −$339.7K | −93.4%3.00K after | |
| Sep 14, 2021 (view filing) | Sep 13 | 1 day | Janda KimDirector | SSale | −8.00K | $8.04 | −$64.3K | −72.7%3.00K after |